cancer gene therapy (Kobe University)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Namecancer gene therapy (Kobe University)

Drug Alias Nameosteocalcin promoter (Kobe University)

ClassificationCell and gene therapy > Gene therapy

Mechanisms of ActionThymidine kinase stimulants

TargetsThymidine kinase

Therapy Area/IndicationsProstatic NeoplasmsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesKobe University

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesKobe University

Active IndicationsN/A

Inactive IndicationsProstatic NeoplasmsNeoplasms

ATC CodeN/A